# CVS HEALTH CORPORATION (CVS) · Edgar & Edgarette company card

> Cvs Health (CVS) grew revenue 7.8% in FY2025 to $402.1 billion, operating margin 1.2% against a 0.6% median for drug stores and proprietary stores, equity 29.7% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 64803 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/CVS) · [JSON](https://www.pops4.com/boards/company/CVS.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $402.1B |
| Revenue growth, 1 year | 7.8% |
| Revenue growth per year | 8.3% |
| Operating margin | 1.2% (prior year 2.3%) |
| Net margin | 0.4% |
| Operating cash flow | $10.6B |
| Capital spending | $2.8B |
| Free cash flow | $7.8B |
| Cash | $8.5B |
| Long-term debt | $64.6B |
| Total assets | $253.5B |
| Total equity | $75.2B |
| Equity ÷ assets | 29.7% |
| Return on equity | 2.4% |
| Dividend per share | $2.66 |
| Dividend years rising | 0 |

## Readings, computed from those figures

- Altman Z: 0.99 (distress zone)
- Piotroski F: 7 of 9 (solid)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $402.1B (FY2025), total debt $64.6B. Experience: revenue up 7.8% on the year, up 8.3% a year over 4 years; operating margin 1.2%, down from 2.3%. Soundness: equity 29.7% of assets, return on equity 2.4%, payout 192.1% of profit. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $390.9B and $449.4B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $367.7B to $475.2B. A statistical range, not company guidance. Against peers (57 filers, $50M+ revenue, its industry group): operating margin 1.2% against a 0.6% median; growth 7.8% against 4.1%.

Range logged 2026-09-26, receipt d565283a29cdd0db, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-08-17 ([filing](https://www.sec.gov/Archives/edgar/data/64803/000119312526354096/0001193125-26-354096-index.htm))

## Recent filings

- 8-K · filed 2026-08-17 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/64803/000119312526354096/0001193125-26-354096-index.htm)
- 10-Q · filed 2026-08-05 · [filing](https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm)
- 8-K · filed 2026-08-05 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/64803/000006480326000097/0000064803-26-000097-index.htm)
- 8-K · filed 2026-05-18 · 5.02 Departure or Election of Directors; Appointment of Officers; 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/64803/000006480326000082/0000064803-26-000082-index.htm)
- 10-Q · filed 2026-05-06 · [filing](https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm)
- 8-K · filed 2026-05-06 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/64803/000006480326000051/0000064803-26-000051-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000064803.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=64803

## Cite

POPS4, Edgar & Edgarette: CVS HEALTH CORPORATION (CVS) company card, from the company's own SEC filings, accessed 2026-11-02, https://www.pops4.com/boards/company/CVS. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.